Spirochetosis of the colon was first reported in 1967 in a patient with chronic diarrhea. 1 Since this first description, however, the clinical significance of spirochetosis has been controversial, as its relationship with human disease has remained unclear. Spirochetosis has been associated with abdominal pain, appendicitis, chronic diarrhea, and rectal bleeding in some cases, 2, 3 but in the majority of cases, spirochetosis is an incidental finding with no clear clinical correlates.
The anaerobic intestinal spirochetes Brachyspira aalborgi and Brachyspira pilosicoli seem to be responsible for most cases of spirochetosis. B aalborgi was cultured from a case of colonic spirochetosis in 1982, 4 and most subsequent cases diagnosed via surgical biopsy specimens were assumed to be B aalborgi based on similar morphologic features. However, a role for B pilosicoli also seemed likely because B pilosicoli colonizes the intestinal tract of many animal species, especially pigs, 5 and can be found in approximately 30% of feces from persons in developing countries. [6] [7] [8] Subsequent studies seemed to confirm a major role for B pilosicoli, as it was the predominant species cultured from stool. 9 In contrast, after the initial report associating B aalborgi with spirochetosis, B aalborgi was cultured from only 1 additional patient. 10 Thus, the recent results of retrospective studies using polymerase chain reaction (PCR)-based assays on paraffin-embedded tissue samples were of interest when they showed that most cases from several Western countries (predominantly Scandinavia and Australia) were associated with B aalborgi, not the expected B pilosicoli. [11] [12] [13] [14] We undertook a retrospective analysis of colonic spirochetosis at a tertiary care center to provide additional clinical pathologic information on this entity and determine the genotype of the spirochete species in a US cohort using a PCR-based assay.
Materials and Methods

Case Selection
Computer files at the Johns Hopkins Hospital, Baltimore, MD, were reviewed retrospectively to identify all cases diagnosed as spirochetosis from January 1994 to January 2002. All identified cases had paraffin blocks available and were included in the study. The study was conducted with approval from the Johns Hopkins Medical School Institutional Review Board.
DNA Analysis
Ten-micrometer sections of paraffin-embedded tissues were microdissected under ×40 magnification with a 27½-gauge needle, and genomic DNA then was extracted with Proteinase K digestion, 1 mg/mL at 56°C for 16 hours. The primers for PCR were designed to anneal to conserved regions of the 16S ribosomal RNA gene and amplify a nonconserved 241-base-pair region, permitting species identification based on sequence alignment. The genomic DNA sequences of B aalborgi and B pilosicoli used for primer design were GeneBank accession numbers Z22781 and AY155458, respectively. PCR was performed in 50 µL volumes using an 0.8 µmol/L concentration of both 5' (5'-GCGAACTGGTGAGTAACACG-3') and 3' (5'-GAGTCTGGGCCGTATCTCAG-3') oligonucleotides. The following conditions were used: 94°C for 1 minute, 58°C for 1 minute, and 72°C for 1 minute for 40 cycles. Amplicons were detected by electrophoresis in 1% agarose gels with ethidium bromide and then were purified (QIAquick-spin PCR purification kit, Qiagen, Valencia, CA) and directly sequenced.
Results
Clinical Findings
Fourteen cases were identified, including 3 females and 11 males. Four cases were found in children (median age, 12 years), and 10 cases in adults (median age, 50 years). Only 2 of the men had HIV infections. None of the non-HIV infected adults were clinically immunosuppressed, although 1 had colon carcinoma and another a history of active alcohol abuse.
All children and both HIV-infected men sought care because of complaints of abdominal pain, diarrhea, or both. In contrast, only 1 of the remaining adults had gastrointestinal symptoms, and most underwent colonoscopy for other reasons ❚Table 1❚. Treatment and follow-up information was not available for most cases. Two patients were treated, with resolution of symptoms in case 1; case 10 was lost to further follow-up. Follow-up biopsy specimens also were available for 2 patients who did not receive treatment: one case showed persistent spirochetosis, while the other was negative.
Histologic Findings
A median of 5 colorectal sites were sampled for each patient (range, [1] [2] [3] [4] [5] [6] [7] [8] [9] diagnosis were available for 6 cases. Histologically, spirochetosis was characterized by a uniform 2-to 3-µm-thick layer of basophilic organisms adherent to the surface epithelium ❚Image 1❚. Spirochetosis was identified in all parts of the colon ❚Table 2❚ and typically involved all tissue fragments and all specimen locations. However, rectal biopsy specimens occasionally were negative. Likewise, the terminal ileum was biopsied in 2 patients, and both had negative results for spirochetosis. While 4 of 14 cases had cryptitis, the active inflammation was focal and mild and not clearly associated with the spirochetes. In 1 case with tubular adenomas and 1 with cecal carcinoma, the spirochetes were present only on the nonadenomatous epithelium. In contrast, spirochetes were present on the adenomatous epithelium in another case with tubular adenomas. One additional case had hyperplastic polyps with adherent spirochetes.
DNA Analysis
Spirochete DNA was amplifiable in 13 of 14 cases. Two cases were classified as B pilosicoli based on sequence comparison, while the remaining 11 cases were classified as B aalborgi. No clear association was evident between species and clinical or pathologic findings.
Discussion
The prevalence of spirochetosis varies from 2.5% to 16% in Western countries 15, 16 and is significantly higher in the developing world and in homosexual men, with prevalence as high as 50%, based on stool culture [6] [7] [8] 17 and biopsy findings. 9, 17 Spirochetosis is identified histologically as a densely packed layer of organisms attached to the luminal surface of colonic epithelium. Most cases can be identified readily on H&E-stained sections, although silver stains also can be used to highlight the organisms and can detect cases not evident on routine H&E stains. 17, 18 Our study confirms the male predominance previously reported, 2 as well as the ability of spirochetes to colonize adenomatous epithelium. 19 In addition, our results highlight the diffuse colonic distribution of the organisms. Similarly to the findings of Surawicz et al, 17 our results indicate rectal sparing in several cases, although others have reported a higher frequency of rectal involvement. 2 Furthermore, the results of the present study extend our understanding of the species distribution, highlighting the predominance of B aalborgi as the major causative agent of spirochetosis in the United States. Perhaps ironically, the species associated with spirochetosis has come full circle, from an assumption that most cases are B aalborgi based on report of an initial culture result, to associating most cases with B pilosicoli based on culture of biopsy specimens, 9 back to B aalborgi based on genotypic analysis. In this regard, B aalborgi is reportedly much more difficult to culture than B pilosicoli. 10, 20 We observed no significant clinical or histologic differences between the 2 species. However, the number of B pilosicoli cases in this study was small, and our results do not exclude the potential for real differences in the clinicopathologic import of these 2 species, in particular given multiple lines of evidence from other sources. For example, in poultry, B pilosicoli causes colonic disease, while B aalborgi does not. 20 B pilosicoli also is a recognized cause of diarrhea in farm animals. 5 It is interesting to note that B pilosicoli also has been cultured from the blood of several critically ill humans. 21 This study is limited partially because of its retrospective nature, in which reliance on previously diagnosed specimens is likely to miss a proportion of cases, in particular because silver stains were not performed routinely. 17, 18 However, this limitation does not detract substantially from our findings because our goal was not to establish the overall prevalence. Also, our observations are limited by the lack of clinical follow-up for most cases, reflecting the prevailing opinion that the diagnosis of spirochetosis is clinically irrelevant. In fact, much of the literature has not supported treatment for colonic spirochetosis. For example, in a study of 15 patients by Nielsen et al, 22 treatment effectively eliminated the organisms but did not lead to clinical improvement. However, our findings of clinical improvement in 1 case after treatment adds to a growing number of case reports and case series associating treatment with resolution of symptoms in some cases, 12, 23, 24 especially children. 12, 24 Thus, while many cases might not require therapy, especially those that are incidental findings, treatment in symptomatic cases might be effective in selected people. Both specific and nonspecific treatments (for diarrhea) alleviated symptoms in the cases in the present study and in other studies. 23, 25 While all 4 children in the present study had clinical symptoms, it is unclear whether pediatric spirochetosis is associated specifically with clinical symptoms, as essentially all pediatric colonoscopy studies are performed in the setting of abdominal complaints, while a large proportion of adult colonoscopies are performed as screening procedures. Thus, the association noted in the present study between symptoms and children also is likely to be encountered in the practice of diagnostic surgical pathology but might be due to "referral bias." Specific epidemiologic studies would be required to further clarify this issue.
Spirochetosis in the present series had a male predominance and a diffuse colonic distribution and predominantly was due to B aalborgi. While treatment information remains limited, treatment leads to resolution of symptoms in some cases.
